Alzheimer's update: Grifols, one of the world’s largest plasma-protein companies, will start a 300-patient trial in 2011 of IVIG for AD in direct competition with BAX’s Gammagard:
All of the plasma-protein companies will have to jump on the AD bandwagon in due course because the upside is too large to ignore. Octapharma announced its own plans for such a program a few weeks ago (#msg-49232696).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.